Orphan designated drug SAGE-547 was recently used
successfully to treat super-refractory status epilepticus (SRSE) in two
pediatric patients. The report by Broomall et al  is available at the Annals of Neurology
(online ahead of
print). SAGE-547 is being developed by Sage Therapeutics.
Super-refractory status epilepticus is frightening version of status
epilepticus, which on its own can be a life-threatening condition (35,000 of a
total of 150,000 die from it each year). When a patient presents with
status epilepticus, they are usually treated with benzodiazepines, and if no
response, they are treated with second-line, anti-seizure drugs.
This is a follow up to my article, "Marijuana and Colorado, a Doctor's Perspective". The venture capitalists are moving in. This was inevitable, as I talked about it in my article. It has become difficult for any investor to ignore the glaring reality of an American "Medical Cannabis economic boom" coming sooner than most are ready for. Start paying attention.
The latest on Novus from Venture 17 and The Trinity Venture Capital Group. Read on.
Novus (NDEV) Aims to
Fill Key Void in Cannabis Industry
While teaching my campus based class on Professional
Development this term, it became evident that I needed to write this article. It
seems every term, the subject of “What should I do with my money, Dr. Counce?”
always comes up. They are truly eager to learn, but young college students in
their twenties struggle with the task of managing their money, let alone
getting it to work for them. And really, because no one has ever shown most of them
this part of the free enterprise system we live in.
Honestly, how many of you
who went to public schools like I did, ever learned about economics and
investment vehicles before college?
Between now and
the end of 2014, the US Department of Labor is predicting a thirty percent
increase in the number of health care jobs. This will amount to approximately five
million new employees in the field of health care and one out of every five of
these jobs will be in the field of health services. The challenges facing
health care organizations will be immense as they try to develop and implement
strategic plans to recruit and train a quality workforce. Retention of these
employees will be a key factor in minimizing operating budgets due to the high
cost of employee turnover, which in a study conducted by the American Association of Retired Persons (AARP), can amount
to up to fifty percent of payroll dollars.